High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer: Acute toxicity

Autor: Roberto Alonzi, Peter Hoskin, Ana M. Rojas, Peter Ostler, Linda Bryant, Robert Hughes, Gerry Lowe

Publikováno v: Hoskin, P, Rojas, A, Ostler, P, Hughes, R, Alonzi, R, Lowe, G & Bryant, L 2014, ' High-dose-rate brachytherapy alone given as two or one fraction to patients for locally advanced prostate cancer : acute toxicity ', Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, vol. 110, no. 2, pp. 268-71 . https://doi.org/10.1016/j.radonc.2013.09.025

BACKGROUND: To evaluate early urinary (GU) and gastrointestinal (GI) adverse events (AEs) after two or one fraction of high-dose rate brachytherapy (HDR-BT) in advanced prostate cancer.PATIENTS AND METHODS: 165 patients were treated with 2 × 13 Gy (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::076c5ca06dd92ca89eb0315cf6109072
https://doi.org/10.1016/j.radonc.2013.09.025